(58 days)
The TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant is used for contraception and for prophylactic purposes (to prevent pregnancy and the transmission of sexually transmitted infections).
The TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant is made of a natural rubber latex sheath, which completely covers the penis with a fitted membrane and has a warming lubricant applied directly to the condom to create a perception of warming. The condom is a bulbous shaped condom with 11 rows of continuous ribs on the shaft and 9 rows of continuous ribs on the bulb. The TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant meets the specifications of ASTM D3492-16. The condom has a nominal length of 185 mm and a nominal flat width of 54 mm, measured 30 mm from the open end. The bulbous part at the closed end of the condom has a flat width of 65 mm.
While the provided text describes the performance testing and safety testing conducted for the TROJAN™ Her Pleasure Warming male natural rubber latex condom, it does not explicitly use the term "acceptance criteria" in a structured table or provide a detailed study that directly proves the device meets specific acceptance criteria in the way a clinical trial or AI model validation study would.
Instead, the document details a 510(k) Premarket Notification for a medical device seeking substantial equivalence to a legally marketed predicate device. In this context, "acceptance criteria" are implicitly met by demonstrating that the device performs equivalently to established standards (ASTM D3492-16, ISO 4074:2015) and passes various safety evaluations (biocompatibility).
Here's an attempt to structure the information according to your request, acknowledging that some details, especially regarding a "study that proves the device meets acceptance criteria" in the context of AI or specific clinical efficacy endpoints, are not present for this type of device (a condom):
Acceptance Criteria and Device Performance for TROJAN™ Her Pleasure Warming Condom
1. Table of Acceptance Criteria and Reported Device Performance:
| Acceptance Criteria Category | Specific Acceptance Criteria (Implicit from Standards/Tests) | Reported Device Performance |
|---|---|---|
| Physical Performance | Airburst specifications (ASTM D3492-16) | Met airburst specifications of ASTM D3492-16 at baseline. |
| Shelf Life/Stability | Compliance with ASTM D3492-16 and ISO 4074:2015 over time; FDA expiration labeling requirements (21 CFR §801.435) | Initial expiration date set at 36 months, to be verified through real-time stability for 5 years. Results of physical testing data demonstrated stability. |
| Biocompatibility | Non-cytotoxic (ISO 10993-5) | Passed (results demonstrate biocompatibility). |
| Non-irritating (Rabbit Vaginal, Rabbit Penile, Primary Rabbit Skin Irritation) (ISO 10993-10) | Passed (results demonstrate biocompatibility). | |
| Non-sensitizing (Guinea Pig Maximization Sensitization) (ISO 10993-10) | Passed (results demonstrate biocompatibility). | |
| Non-acutely toxic (Acute Systemic Toxicity) (ISO 10993-11) | Passed (results demonstrate biocompatibility). | |
| Intent to Market | Substantial Equivalence to Predicate Device | Determined substantially equivalent (same intended use, indications for use, product code, dimensions, shelf-life, primary packaging; technological differences in rubber/lubricant formulations do not raise new safety/effectiveness questions as they match cleared reference devices). |
2. Sample Size Used for the Test Set and Data Provenance:
- Physical Testing (Airburst): "Three (3) lots" of condoms were tested. No specific number of individual condoms per lot is provided.
- Shelf Life: The stability was established through "physical testing data using a protocol that followed 21 CFR §801.435 and met the requirements of both ASTM D3492-16 and ISO 4074:2015." The sample size (number of condoms tested over time) is not explicitly stated.
- Biocompatibility: The text lists several specific tests (e.g., Rabbit Vaginal Irritation, Guinea Pig Maximization Sensitization). The "sample size" for these biological tests typically refers to the number of animals or cell cultures used, which is not detailed in this summary.
- Data Provenance: Not explicitly stated, but given these are standard tests for medical device approval in the US, it's implied they were conducted in a controlled lab environment. It is not specified if the data is retrospective or prospective, but testing for device approval is inherently prospective relative to market entry.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
This type of information is generally not applicable to the evaluation of a condom for physical and biological safety. The "ground truth" for condom performance is established by adherence to internationally recognized standards (ASTM D3492-16, ISO 4074:2015) and standard biocompatibility testing protocols, not by expert consensus on clinical readings or interpretations. Labs performing these tests are accredited to do so.
4. Adjudication Method for the Test Set:
Not applicable in the context of objective physical and biological tests. Adjudication methods (like 2+1 or 3+1) are typically used in clinical studies where expert consensus is needed to establish a "ground truth" for complex diagnostic or treatment outcomes, often involving subjective interpretation (e.g., imaging reads). Here, results are pass/fail based on objective measurements and established thresholds.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done:
No, an MRMC comparative effectiveness study was not conducted. This type of study is typically performed for diagnostic devices (like AI-assisted imaging software) to evaluate how AI impacts human reader performance. The device here is a physical contraceptive/prophylactic, not a diagnostic tool requiring human interpretation.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done:
Not applicable. This device is a physical product, not an algorithm.
7. The Type of Ground Truth Used:
The "ground truth" for the performance of this device is based on:
- Objective Standards: Adherence to established international and national standards for rubber contraceptives (e.g., ASTM D3492-16, ISO 4074:2015) for physical properties like airburst and stability.
- Standardized Biocompatibility Protocols: Results from well-defined biological evaluations (ISO 10993 series) for cytotoxicity, irritation, sensitization, and acute systemic toxicity.
8. The Sample Size for the Training Set:
Not applicable. As a physical product, there is no "training set" in the machine learning sense. The development of the condom involves engineering, material science, and manufacturing processes, not algorithm training.
9. How the Ground Truth for the Training Set Was Established:
Not applicable, as there is no training set in the context of this device. The development and verification processes for condoms rely on established scientific and engineering principles, material specifications, and regulatory standards rather than machine learning ground truth establishment.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the symbol of the Department of Health & Human Services on the left and the FDA acronym with the full name of the agency on the right. The FDA part is in blue, with the acronym in a solid blue square and the full name written in a smaller font next to it.
July 14, 2022
Church & Dwight Co., Inc. % Dawn Reilly-O'Dell Principal Full Circle Regulatory Consulting, LLC 107 Casablanca Court Cary, NC 27519
Re: K221431
Trade/Device Name: TROJAN™ Her Pleasure Warming male natural rubber latex condom with warming lubricant Regulation Number: 21 CFR§ 884.5300 Regulation Name: Condom Regulatory Class: II Product Code: HIS Dated: May 12, 2022 Received: May 17, 2022
Dear Dawn Reilly-O'Dell:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jason R. Roberts, Ph.D. Assistant Director DHT3B: Division of Reproductive, Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K221431
Device Name
TROJAN™ Her Pleasure Warming male natural rubber latex condom with warming lubricant
Indications for Use (Describe)
The TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant is used for contraception and for prophylactic purposes (to prevent pregnancy and the transmission of sexually transmitted infections).
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
X Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) Summary
| Submitter Name: | Church & Dwight Co., Inc. |
|---|---|
| Submitter Address: | 500 Charles Ewing Boulevard, Ewing, NJ 08628 |
| Submitter Contact Person: Supreet Sahota-BhattiSr. Manager, Global Regulatory Affairs (US)Church & Dwight Co., Inc., 469 North Harrison Street, Princeton, NJ 08543Tel: (609)806-7893 | |
| Preparer Name: Dawn Reilly-O'Dell, RAC, MPHPrincipal, Full Circle Regulatory Consulting, LLCEmail: dreilly@fullcirclereg.com | |
| Date Prepared: | May 12, 2022 |
| Trade Name: | TROJAN™ Her Pleasure Warming male natural rubber latex condom withwarming lubricant |
| Common Name: | Natural Rubber Latex Condom |
| Product Code: | HIS (condom) |
| Regulatory Class: | Class II |
| Classification Name: | Condom (21 CFR § 884.5300) |
| Predicate Device: | K131887: TROJAN™ Jaguar Male Natural Rubber Latex Condom with Warmingand Tingling Lubricant |
| The predicate device has not been subject to a design related recall. | |
| Reference Devices: | K120249: TROJAN™ MAGNUM Male Latex Condom with Warming LubricantK092586: Male Natural Latex Condom |
Description of Device:
The TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant is made of a natural rubber latex sheath, which completely covers the penis with a fitted membrane and has a warming lubricant applied directly to the condom to create a perception of warming. The condom is a bulbous shaped condom with 11 rows of continuous ribs on the shaft and 9 rows of continuous ribs on the bulb. The TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant meets the specifications of ASTM D3492-16. The condom has a nominal length of 185 mm and a nominal flat width of 54 mm, measured 30 mm from the open end. The bulbous part at the closed end of the condom has a flat width of 65 mm.
{4}------------------------------------------------
Intended Use of the Device:
The TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant is used for contraception and for prophylactic purposes (to prevent pregnancy and the transmission of sexually transmitted infections).
Predicate Device Comparison:
The subject and predicate device have the same intended use and indications for use. The subject and predicate device share the same product code, indications for use, dimensions, shelf-life, and primary packaging. Both are lubricated natural rubber latex condoms, but the formulations of their natural rubber latex and lubricant differ. These differences in technological characteristics do not raise different questions of safety and effectiveness, and both the natural rubber latex and lubricant formulations of the subject device are the same as the natural rubber latex and lubricant formulations of legally marketed, 510(k) cleared reference devices.
Summary of Performance Testing
Physical Testing Data: Three (3) lots of TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant were tested at baseline and met airburst specifications of ASTM D3492-16 Standard Specifications for Rubber Contraceptives (Male Condoms).
Shelf Life: Stability of the TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant was established from results of physical testing data using a protocol that followed 21 CFR §801.435 and met the requirements of both ASTM D3492-16 and ISO 4074:2015. Based on the evaluation of the results of the physical testing data, the expiration date has been initially set at 36 months (about 3 years) and will be then verified through real-time stability through five (5) years in compliance with FDA expiration labeling requirements in 21 CFR §801.435.
Summary of Safety Testing
Biocompatibility: Biocompatibility evaluations were performed on the TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant in accordance with ISO 10993-1:2018, Biological Evaluation of Medical Devices.
| Evaluation (biological endpoint) | ISO Standard |
|---|---|
| Cytotoxicity ISO Elution Method | ISO 10993-5 |
| Rabbit Vaginal Irritation | ISO 10993-10 |
| Rabbit Penile Irritation | ISO 10993-10 |
| Primary Rabbit Skin Irritation | ISO 10993-10 |
| Guinea Pig Maximization Sensitization | ISO 10993-10 |
| Acute Systemic Toxicity | ISO 10993-11 |
Table 1: Biocompatibility Evaluations Conducted
The results of these evaluations demonstrate that the subject device is biocompatible.
{5}------------------------------------------------
Conclusion:
Based on the results of the testing and data described above, the TROJAN™ Her Pleasure Warming natural rubber latex condom with warming lubricant is as safe and effective as the predicate device. The performance data support a determination of substantial equivalence.
§ 884.5300 Condom.
(a)
Identification. A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.(b)
Classification. (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.